Biomarkers are essential in lung cancer treatment, but they remain underutilized. In addition, clinicians and patients have to wait for those results before sta ...
11/13/2025
📣 Nominations Are Now Open!
The IASLC is proud to announce the opening of nominations for the 2026 IASLC Distinguished Service and Lectureship Awards!
These prestigious honors recognize outstanding leadership, scientific excellence, and lifelong contributions to the global thoracic oncology community.
🗓️ Nomination window: Now–Dec 24, 2025 (12 PM MST)
🗓️ Self-nomination/acceptance: Through Jan 14, 2026 (12 PM MST)
From the Paul A. Bunn, Jr. Scientific Award to the Fred R. Hirsch Lectureship Award, we celebrate individuals advancing the understanding and treatment of lung cancer worldwide.
Dr. Yasushi Yatabe said the latest findings from the JCOG0802/WJOG4607L trial support consideration of adjuvant treatments, rather than conversion from segmentectomy to lobectomy.
Learn more in ILCN: https://bit.ly/4nl8ijw
JCOG0802/WJOG4607L data validate segmentectomy as non-inferior to lobectomy, regardless of the presence of STAS, Dr. Yasushi Yatabe said.
11/11/2025
NEW!
The U.S. FDA has cleared a combination medication for patients with extensive-stage small cell lung cancer whose disease has not progressed following first-line induction therapy.
FDA clears a combination medication for extensive-stage small cell lung cancer for patients whose disease has not progressed after first-line induction therapy.
11/09/2025
Help Shape How Patient Experiences Are Measured!
IASLC invites you to join our effort to improve the use of patient-reported outcomes (PROMs) in lung cancer research. Take a short, anonymous survey to share your thoughts on consensus statements about PROMs in early-stage and radically treated lung cancer trials.
Your feedback will help shape the future of patient-centered research!
"When we detect lung cancer early, we don’t just improve survival, we give people hope.”
On National Lung Cancer Screening Day, Keelan Zius, IASLC's Scientific Program Manager, reminds us that screening saves lives.
👉 Low-dose CT screening can catch lung cancer early, before symptoms appear.
👉 Screening can reduce deaths by 20% or more among people at higher risk.
Let’s spread the word, reduce stigma, and empower more people to talk to their doctors about screening.
11/08/2025
“I didn’t know a persistent cough could be a sign of something more serious.”
This Lung Cancer Awareness Month, Annabelle Gurwitch, lung cancer survivor and advocate, reminds us that early detection saves lives.
Let’s spread awareness and advocate for better lung cancer screening for everyone.
11/05/2025
Closing soon: IASLC Academy Applications must be submitted by November 10!
Are you an early-career professional in thoracic oncology looking to take the next step? The 2026 IASLC Academy is your opportunity to learn from global experts, strengthen your core professional skills, and gain hands-on experience that will shape your career.
Program Highlights:
- Expert Mentorship: Learn directly from global leaders in oncology, pathology, thoracic surgery, and more.
- Core Skills: Build strengths in grant writing, communication, and global problem-solving.
- Hybrid Learning: Join several virtual sessions and an in-person experience at WCLC 2026 in Seoul, Republic of Korea, with potential travel support available.
Don’t miss your chance to join a truly international community of future leaders in thoracic oncology.
Apply now: https://bit.ly/3WFQjty
11/04/2025
New Episode Alert!
Throughout November, Lung Cancer Considered is spotlighting stories that honor Lung Cancer Awareness Month.
This week, host Dr. Narjust Florez speaks with Samantha Murrell and Megan Flanagan, two young advocates who are redefining what it means to live with lung cancer.
They share their journeys from diagnosis to advocacy, challenging misconceptions, inspiring hope, and highlighting the power of community.
In this episode of Lung Cancer Considered, host Dr. Narjust Florez speaks with two remarkable young lung cancer advocates Samantha Murell and Megan Flanagan, wh ...
11/03/2025
We’re revisiting this powerful episode of Lung Cancer Considered to mark Lung Cancer Awareness Month.
In this moving conversation, Dr. Bryant Lin, a Stanford physician who spent years leading lung cancer awareness efforts before being diagnosed with stage IV lung cancer, shares how he turned his diagnosis into a lesson for the world.
During treatment, he launched a class on cancer care, inviting students, colleagues, and patients to see cancer not just as an illness, but as a powerful teacher.
Hear Dr. Lin’s discussion with Dr. Stephen Liu on resilience, empathy, and what it truly means to live and learn through lung cancer.
In this episode of Lung Cancer Considered, host Dr. Stephen Liu speaks with Dr. Bryant Lin, Clinical Professor of Medicine at Stanford University and co-founder ...
11/01/2025
🤍 It’s Lung Cancer Awareness Month!
Earlier this year, the 78th World Health Assembly adopted the World Health Organization’s resolution on lung health, highlighting the urgent need to tackle lung cancer and other respiratory diseases worldwide.
Research is improving outcomes every day, and the IASLC community, patients, clinicians, and researchers work tirelessly to fight this disease.
🚨 Last Chance to Save! 🚨
Early-bird pricing for TTLC 2026 ends today. Don’t miss your chance to join global experts in Huntington Beach, California, for the IASLC Targeted Therapies of Lung Cancer Meeting.
Submit your abstract by November 18 to share your research with leaders in targeted lung cancer therapies. Early-career presenters are invited to an exclusive Roundtable Lunch with senior mentors!
Be the first to know and let us send you an email when International Association for the Study of Lung Cancer posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Practice
Send a message to International Association for the Study of Lung Cancer:
The International Association for the Study of Lung Cancer (IASLC) is on a mission to conquer thoracic cancers worldwide. Through hosting global conferences, funding cutting-edge research and educating the health care community and the general public on all aspects of thoracic cancers, the IASLC strives to alleviate the burden lung cancer places on patients, families and communities.
Each year, the IASLC hosts the World Conference on Lung Cancer (WCLC), the world’s largest meeting dedicated solely to thoracic cancers. The WCLC regularly attracts over 7,000 thoracic cancer specialists from over 100 countries and offers attendees the chance to collaborate and network while learning about the latest updates in the field.
The IASLC Foundation supports the education of research fellows - who are the next generation of lung cancer physicians and scientists - by funding research fellowships. Since its inception, the foundation has given nearly $3.5 million to lung cancer research, and that number is on the rise.
Additionally, the IASLC publishes the Journal of Thoracic Oncology (JTO), a primary source for educational information related to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Over its publication history, the JTO has established itself as an authoritative resource in the field, and the journal recently saw its impact factor increase from 6.595 in 2016 to 10.336 in 2017.
The IASLC is a global and multidisciplinary organization that desires to build a international and inclusive lung cancer community. Whether you are an oncologist or surgeon, advocate or patient, we welcome your expertise, experience and voice in the ongoing fight against lung cancer. Join us!
